CDK4/6i mechanism of action is centered on Retinoblastoma protein (Rb), the product of the retinoblastoma tumor susceptibility gene (RB1), which is the main target of the CDK4/6-cyclin D complex and has a critical role in cell cycle regulation [38]. The gene discussed is RB1; the disease is neoplasm.